If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
IPO today
Upcoming IPO
Biofrontera (BFRI)
Marpai (MRAI)
Cingulate, Inc. (CING)
Stronghold Digital Mining, Inc. (SDIG)
Enfusion, Inc. (ENFN)
Portillos Inc. (PTLO)
Winc, Inc. (BEV)
The Vita Coco Company, Inc. (COCO)
P10, Inc. (PX)
Ventyx Biosciences, Inc. (VTYX)
Winc, Inc. (WBEV)
Runway Growth Finance Corp (RWAY)
Aris Water Solutions, Inc. (ARIS)
Minerva Surgical, Inc (UTRS)
Xilio Therapeutics, Inc. (XLO)
Informatica Inc. (INFA)
Arteris, Inc. (AIP)
Priced IPO
Mink Therapeutics, Inc. (INKT)
Paragon 28, Inc. (FNA)
Ihs Holding Limited (IHS)
Gitlab Inc. (GTLB)
Lucid Diagnostics, Inc. (LUCD)
Healthcare Triangle (HCTI)
AvidXchange (AVDX)
Cognition Therapeutics, Inc. (CGTX)
Isoplexis Corporation (ISO)
Pyxis Oncology, Inc. (PYXS)
Life Time Group Holdings, Inc. (LTH)
Theseus Pharmaceuticals, Inc. (THRX)
Tricon Residential (TCN)
Volcon (VLCN)
Nuvei (NVEI)
Tdcx, Inc. (TDCX)
First Watch Restaurant Group, Inc. (FWRG)
Exscientia Limited (EXAI)
Warby Parker (WRBY)
Olaplex Holdings Inc. (OLPX)
More companies

Paragon 28, Inc. (FNA)

Sector - Healthcare

Price chart

Return from IPO

Company News

IPO Profile

About company

They are a leading medical device company exclusively focused on the foot and ankle orthopedic market and they are dedicated to improving patient lives. Their innovative orthopedic solutions, procedural approaches and instrumentation cover a wide range of foot and ankle ailments including fracture fixation, hallux valgus (bunions), hammertoe, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, charcot foot and orthobiologics. To treat these painful, debilitating or even life-threatening conditions, they provide a comprehensive portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. Their broad suite of surgical solutions comprises 72 product systems, including approximately 8,700 SKUs to help fit the specific needs of each patient and procedure. They design each of their products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent and reproducible. They believe their passion, expertise, and exclusive focus in the foot and ankle market has allowed them to better understand the needs of their patients and physicians, which has enabled them to create innovations and enhanced solutions that disrupt and transform the foot and ankle market. As a result, they have experienced significant growth and momentum in their business.
Surgical & Medical Instruments & Apparatus
Employees Founded
295 2010


Address: 14445 Grasslands Drive, Englewood, Co 80112, Us

Telephone: (730) 399-3400

Web page:

IPO information

First Trade Date 10/15/2021
Status Priced
Exchange NYSE
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
Share prices ($)

Shares & Volumes

Shares Initial (MM) 7.8
Shares Revised (MM) 7.8
Expected offer amount (MM) $124.8
Realized offer amount(MM) $124.8

Financial Data (last reporting year)

Market Cap (MM) $1203.2
Revenues (MM) $134.2
Net Income (Loss) (MM) $2.39


What do you think will happen with the FNA share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: BofA Securities

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
BofA Securities/ Piper Sandler
Canaccord Genuity/ JMP Securities/ Needham & Co.

Sector: Healthcare

Tweets about $FNA

Tweets volume:

RT volume:


Google Trends Stats